• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR PIPELINE FLEX W/SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR PIPELINE FLEX W/SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number PED2-475-18
Device Problems Activation Failure (3270); Migration (4003)
Patient Problem Paresis (1998)
Event Date 07/01/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received a report that the patient was seen 3 months post procedure showing left side hemiparesis with both upper and lower having 4/5 power.A dsa performed showed 90% stenosis proximally with stent migration and distal stent narrowing.As a result the proximal stenosis was angioplastied with a 3 mm sterling balloon with a good result seen and the patient's symptoms resolving.In (b)(6) 2018 the patient returned again with left side hemiparesis and a facial droop.A dsa was again performed which showed the pipeline had lengthened but improved from the angioplasty in (b)(6).The proximal stenosis had a durable result from the prior angioplasty but the distal end remained narrowed.No intervention was performed at that time and the patient's symptoms resolved.The cause of the migration was unknown the patient underwent pipeline placement surgery in (b)(6) 2018 for treatment of an unruptured, saccular supraclinoid ica aneurysm with a ma diameter of 7 mm and neck diameter of 4 mm.It was noted that the vessel tortuosity was normal.There were no issues during the initial procedure with the pipeline deployed easily in the correct location and stasis seen in the aneurysm post deployment.Full wall apposition was achieved and no side branches were covered by the pipeline.The devices were prepared/flushed as indicated per the ifu.Dual antiplatelet treatment was administered with a pru level of 73 and an inhibition of 65%.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE FLEX W/SHIELD TECHNOLOGY
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR
9775 toledo way
irvine CA 92618
Manufacturer Contact
gabriela mclellan
9775 toledo way
irvine, CA 92618
9492753836
MDR Report Key7819994
MDR Text Key118344219
Report Number2029214-2018-00748
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
P100018.S004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 08/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/27/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/06/2020
Device Model NumberPED2-475-18
Device Catalogue NumberPED2-475-18
Device Lot NumberA396899
Was Device Available for Evaluation? No
Date Manufacturer Received08/12/2018
Date Device Manufactured01/06/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age41 YR
-
-